Zbigniew Hruby

Dr. Zbigniew Hruby


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 June 2022 in Antibiotics
Verified
Journal Article
Open access
PDF file
ŁLŁukasz Lis
Łukasz Lis
AKAndrzej Konieczny
Andrzej Konieczny
MSMichał Sroka
Michał Sroka
ACAnna Ciszewska
Anna Ciszewska
KKKornelia Krakowska-Jura
Kornelia Krakowska-Jura
ZHZbigniew Hruby
Zbigniew Hruby
The majority of recently published studies indicate a greater incidence rate and mortality due to Clostridioides difficile infection (CDI) in patients with chronic kidney disease (CKD). The aim of this study was to assess the clinical determinants predicting CDI among hospitalized patients with CKD and refine methods of prevention. We evaluated the medical records of 279 patients treated at a nephrological department with symptoms suggesting CDI, of whom 93 tested positive for CDI. The survey showed that age, poor kidney function, high Padua prediction score (PPS) and patients’ classification of care at admission, treatment with antibiotics, and time of its duration were significantly higher or more frequent among patients who suffered CDI. Whereas BMI, Norton scale (ANSS) and serum albumin concentration were significantly lowered among CDI patients. In a multivariate analysis we proved the stage of CKD and length of antibiotics use increased the risk of CDI, whereas higher serum albumin concentration and ANSS have a protective impact.

Verified
Journal Article
Open access
PDF file
JSJakub Stojanowski
Jakub Stojanowski
AKAndrzej Konieczny
Andrzej Konieczny
ŁLŁukasz Lis
Łukasz Lis
WFWeronika Frosztęga
Weronika Frosztęga
PBPatrycja Brzozowska
Patrycja Brzozowska
MKMagdalena Krajewska
Magdalena Krajewska
The majority of recently published studies indicate a greater incidence and mortality due to Clostridioides difficile infection (CDI) in patients with chronic kidney disease (CKD). Hospitalization, older age, the use of antibiotics, immunosuppression, proton pump inhibitors (PPI), and chronic diseases such as CKD are responsible for the increased prevalence of infections. The aim of the study is to identify clinical indicators allowing, in combination with artificial intelligence (AI) techniques, the most accurate assessment of the patients being at elevated risk of CDI.